Efficacy and safety of daclatasvir and asunaprevir in chronic hepatitis C patients with hemodialysis
Not Applicable
- Conditions
- Chronic hepatitis C with hemodialysis
- Registration Number
- JPRN-UMIN000016181
- Lead Sponsor
- shonan kamakura general hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Not provided
Exclusion Criteria
(1) Decompensated cirrhosis, Liver failure (2)patients with hepatic cell carcinoma (3) Co-infection with hepatitis B virus Co-infection with anti- humanimmunodeficiency virus
Study & Design
- Study Type
- Interventional,observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Sustained virologic response rate at 24 weeks post-treatment
- Secondary Outcome Measures
Name Time Method Safety The factor associated with sustained virologic response Emergence of drug-resistant virus Cumulative incidence of hepatocellular carcinoma